Back to HomeBeta

ICD-10 Coding for MSSA Infection(B95.61, Z22.321, A41.01)

Complete ICD-10-CM coding and documentation guide for MSSA Infection. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Methicillin-Susceptible Staphylococcus AureusStaph aureus infection

Related ICD-10 Code Ranges

Complete code families applicable to MSSA Infection

B95.6-B95.61Primary Range

Staphylococcus aureus as the cause of diseases classified elsewhere

This range includes codes for MSSA when it is the causative agent of other diseases.

Carrier of methicillin-susceptible Staphylococcus aureus

Used for documenting asymptomatic carriers of MSSA.

Sepsis due to MSSA

Primary code for sepsis cases caused by MSSA.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
B95.61Methicillin susceptible Staphylococcus aureus as the cause of diseases classified elsewhereUse when MSSA is identified as the causative organism for another condition.
  • Positive culture for MSSA
  • Documentation of MSSA as causative agent
Z22.321Carrier of methicillin-susceptible Staphylococcus aureusUse for documenting carrier status in the absence of active infection.
  • Positive nasal swab for MSSA
  • No active infection present
A41.01Sepsis due to methicillin susceptible Staphylococcus aureusUse as the primary code for sepsis cases caused by MSSA.
  • Blood cultures positive for MSSA
  • Clinical signs of sepsis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for MSSA infection

Essential facts and insights about MSSA Infection

The ICD-10 code for MSSA infection is B95.61, used when MSSA is the causative agent of diseases classified elsewhere.

Primary ICD-10-CM Codes for mssa

Methicillin susceptible Staphylococcus aureus as the cause of diseases classified elsewhere
Billable Code

Decision Criteria

clinical Criteria

  • MSSA identified in culture

coding Criteria

  • Secondary code for MSSA-related conditions

Applicable To

  • Bacterial osteomyelitis due to MSSA
  • Cellulitis due to MSSA

Excludes

Clinical Validation Requirements

  • Positive culture for MSSA
  • Documentation of MSSA as causative agent

Code-Specific Risks

  • Incorrectly using as a primary diagnosis

Coding Notes

  • Always sequence after the primary condition code.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Carrier of methicillin-susceptible Staphylococcus aureus

Z22.321
Use when documenting carrier status without active infection.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Methicillin resistant Staphylococcus aureus as the cause of diseases classified elsewhere

B95.62
Differentiate based on susceptibility testing results.

Sepsis due to methicillin resistant Staphylococcus aureus

A41.02
Differentiate based on susceptibility testing results.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting MSSA Infection to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code B95.61.

Impact

Clinical: May lead to inappropriate treatment., Regulatory: Non-compliance with coding guidelines., Financial: Potential claim denials.

Mitigation Strategy

Ensure sepsis is documented by the physician, Verify clinical criteria are met

Impact

Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Violates ICD-10 coding guidelines., Data Quality: Affects accuracy of clinical data.

Mitigation Strategy

Always sequence B95.61 after the primary condition code.

Impact

Reimbursement: May affect DRG assignment., Compliance: Incomplete coding of patient status., Data Quality: Inaccurate representation of patient condition.

Mitigation Strategy

Include Z22.321 alongside active infection codes.

Impact

Failure to document carrier status can lead to incomplete coding.

Mitigation Strategy

Ensure carrier status is documented and coded when applicable.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for MSSA Infection, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for MSSA Infection

Use these documentation templates to ensure complete and accurate documentation for MSSA Infection. These templates include all required elements for proper coding and billing.

MSSA Bacteremia

Specialty: Infectious Disease

Required Elements

  • Organism identification
  • Susceptibility testing results
  • Infection site
  • Treatment plan

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has Staph infection - starting antibiotics
Good Documentation Example
MSSA bacteremia confirmed by 2/2 blood cultures (Vitek2: oxacillin susceptible). Initiated nafcillin 2g IV q4h per ID recommendations.
Explanation
The good example specifies the organism, susceptibility, and treatment plan, which are essential for accurate coding and treatment.

Need help with ICD-10 coding for MSSA Infection? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more